Core Insights - On August 29, 2023, Prasis saw a stock price increase of 20.01% with a trading volume of 278 million yuan [1] - As of August 29, 2023, Prasis had a total margin trading balance of 62.69 million yuan, which is 1.82% of its market capitalization, indicating a low financing balance compared to the past year [1] - For the first half of 2025, Prasis reported a revenue of 390 million yuan, a year-on-year decrease of 1.08%, and a net profit attributable to shareholders of 54.16 million yuan, down 1.40% year-on-year [2] Financing and Margin Trading - On August 29, 2023, Prasis had a financing buy amount of 18.66 million yuan and a financing repayment of 20.31 million yuan, resulting in a net financing buy of -1.65 million yuan [1] - The margin trading data indicates that Prasis had no short selling activity on August 29, 2023, with a short selling balance of 0.00 yuan, which is at a high level compared to the past year [1] Shareholder and Institutional Holdings - As of July 31, 2023, Prasis had 8,735 shareholders, a decrease of 7.55% from the previous period, while the average number of circulating shares per shareholder increased by 8.16% to 8,622 shares [2] - As of June 30, 2025, among the top ten circulating shareholders, Tianhong Medical Health A held 1.43 million shares, a decrease of 17,600 shares from the previous period, while Rongtong Health Industry Flexible Allocation Mixed A/B increased its holdings by 100,000 shares to 1 million shares [3]
普蕊斯8月29日获融资买入1866.43万元，融资余额6269.06万元